| Literature DB >> 28003035 |
Sali M K Farhan1, Robert Bartha2, Sandra E Black3, Dale Corbett4, Elizabeth Finger5, Morris Freedman6, Barry Greenberg7, David A Grimes8, Robert A Hegele1, Chris Hudson9, Peter W Kleinstiver10, Anthony E Lang11, Mario Masellis3, William E McIlroy12, Paula M McLaughlin10, Manuel Montero-Odasso13, David G Munoz14, Douglas P Munoz15, Stephen Strother16, Richard H Swartz17, Sean Symons18, Maria Carmela Tartaglia19, Lorne Zinman3, Michael J Strong2.
Abstract
Because individuals develop dementia as a manifestation of neurodegenerative or neurovascular disorder, there is a need to develop reliable approaches to their identification. We are undertaking an observational study (Ontario Neurodegenerative Disease Research Initiative [ONDRI]) that includes genomics, neuroimaging, and assessments of cognition as well as language, speech, gait, retinal imaging, and eye tracking. Disorders studied include Alzheimer's disease, amyotrophic lateral sclerosis, frontotemporal dementia, Parkinson's disease, and vascular cognitive impairment. Data from ONDRI will be collected into the Brain-CODE database to facilitate correlative analysis. ONDRI will provide a repertoire of endophenotyped individuals that will be a unique, publicly available resource.Entities:
Keywords: Alzheimer’s; Amyotrophic Lateral Sclerosis; Dementia; Frontotemporal Dementia; Neurodegeneration; Parkinson Disease; vascular cognitive impairment
Mesh:
Year: 2016 PMID: 28003035 DOI: 10.1017/cjn.2016.415
Source DB: PubMed Journal: Can J Neurol Sci ISSN: 0317-1671 Impact factor: 2.104